Geron Corp (GERN) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts GERN Hot Sheet
Price: $1.57 --0%
Financial Fact:
Loss from operations: -8.91M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Financial Fact:
Loss from operations: -8.91M
Today's EPS Names:
VAXX, EGRX, AFIB, More
Join SI Premium – FREE
Geron Corp (NASDAQ: GERN) reported Q2 EPS of ($0.07), $0.03 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $73 thousand versus the consensus estimate of $105.75 thousand.
For earnings history and earnings-related data on Geron Corp (GERN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Burry doubles down on Nebius short after stock surges 34% on earnings
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- McGraw Hill (MH) Tops Q2 EPS by 11c, Beats on Revenue; Offers FY26 Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
